D-0712-2026 Class II Ongoing
FDA drug recall D-0712-2026 was initiated by Ascend Laboratories, LLC on Jul 8, 2026 and is designated Class II. Reason for recall: Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications The recall status is ongoing. Affected quantity: 6,192 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 29, 2026
- Initiation Date
- Jul 8, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6,192 bottles
Product description
Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30
Reason for recall
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
Distribution pattern
Nationwide in the USA
Code information
Lot 25121311, expiry 3/31/2028
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0712-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026